This makes APCC, India’s first dedicated advanced cancer centre to receive this international accreditation
Apollo Proton Cancer Centre (APCC) today announced its accreditation by Joint Commission International (JCI). This makes APCC, India’s first dedicated advanced cancer centre to receive this international accreditation, and the eight hospital in the Apollo Hospitals Group to join the portfolio of JCI accredited hospitals.
Dr. Prathap C Reddy, Chairman, Apollo Hospitals said, “More than 25 years ago, we noted the growing prevalence of cancer in India, the lack of oncology centres in the country and this was the genesis of Apollo embarking on advanced cancer care. From the very beginning, we brought in the most advanced technologies in cancer care and even the recent launch of South-Asia and the Middle-East’s first proton therapy at Apollo Proton Cancer Centre, reiterates our commitment to investing in the best available care for our patients. I am pleased that Apollo Proton Cancer Centre (APCC) has been accorded a special honour, it is now the first advanced cancer centre in India to be accredited by JCI. This recognition of our quality standards will further strengthen our resolve to keep raising the bar in oncology.”
“The APCC was conceived to be among the best in the world and in keeping with this vision; we have the latest state-of-the-art proton therapy machine with the best team of doctors handling various disciplines in oncology to manage the centre. It is a matter of pride that the top 10 leading cancer care specialists are working with us and to ensure they can deliver the best of care to our patients, we have equipped them with advanced ultra modern medical technology to ensure our centre is a world class proton care centre.”
Preetha Reddy, Vice Chairperson, Apollo Hospitals said, “It was just about 12 months ago, that the very first proton therapy in South-Asia and the Middle-East was unveiled at the Apollo Proton Cancer Centre (APCC) in Chennai. It marked a definitive step ahead by making the world’s most advanced radiation therapy much more accessible, benefitting a population of over 3.5 billion people. Now, once again raising the bar, APCC has become the first dedicated cancer hospital in India to be accredited by JCI, the gold standard for quality. It is also the first successful proton therapy centre accredited by JCI in South-Asia and the Middle-East. Further, this milestone was achieved despite the challenges posed by the pandemic, which underscores the APCC’s commitment to quality and advanced patient care.”
“Joint Commission International (JCI) commends Apollo Proton Cancer Centre for its commitment to meeting international quality and patient safety standards by earning JCI accreditation during the global pandemic,” said Paula Wilson, President and CEO, JCI. “This achievement was possible by utilising JCI’s virtual survey process, where surveys are conducted through the use of technology. This exemplifies how our virtual survey process supports physical distancing and other safety concerns while maintaining the same rigour as a JCI on-site survey.”